CRSP Institutional Ownership & Shareholders

CRISPR Therapeutics AG (CRSP) is currently held by 507 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $5.45B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Banque Cantonale Vaudoise is currently the largest disclosed institutional shareholder of CRSP tracked by InsiderSet, reporting ownership valued at approximately $1.31B in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $1.20M, representing an estimated loss of -99.91% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 66% of the total disclosed CRSP value among the investors covered in this analysis. Major shareholders include Banque Cantonale Vaudoise, ARK Invest, Blackrock, Inc., and several other long-term asset managers with concentrated positions in CRISPR Therapeutics AG (CRSP).

This page ranks the largest institutional CRSP shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

507

Total Reported Value

$5.45B

Largest Holder

Banque Cantonale Vaudoise

Largest Position

$1.31B

Insider Transactions (90d)

12

Latest Filing Quarter

Q2 2026

New Institutional Positions

61

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Banque Cantonale Vaudoise0.18%24,065$1,312,000,000$1,203,009-$1,310,796,991-99.91%
ARK InvestCathie Wood3.35%9,460,939$515,999,631$472,952,341-$43,047,290-8.34%
Blackrock, Inc.0.01%8,348,977$455,353,197$417,365,360-$37,987,837-8.34%
Orbis Allan Gray Ltd1.02%5,449,161$297,197,241$272,403,558-$24,793,683-8.34%
Capital World Investors0.03%4,749,525$259,039,094$237,428,755-$21,610,339-8.34%
State Street Corp0.01%4,321,666$235,703,664$216,040,083-$19,663,581-8.34%
Gsk Plc29.17%3,220,627$175,652,997$160,999,144-$14,653,853-8.34%
Geode Capital Management, Llc0.01%2,509,915$136,919,043$125,470,651-$11,448,392-8.36%
T. Rowe Price Investment Management, Inc.0.07%2,053,017$111,972,000$102,630,320-$9,341,680-8.34%
Sr One Capital Management, Lp10.70%2,038,763$111,194,134$101,917,762-$9,276,372-8.34%
Two Sigma Investments, Lp0.08%1,988,621$108,459,389$99,411,164-$9,048,225-8.34%
Fmr Llc0.00%1,908,503$104,089,735$95,406,065-$8,683,670-8.34%
Amova Asset Management Americas, Inc.1.21%1,720,097$93,762,487$85,987,649-$7,774,838-8.29%
Sumitomo Mitsui Trust Group, Inc.0.05%1,453,713$80,419,403$72,671,113-$7,748,290-9.63%
Ecor1 Capital, Llc3.76%1,389,276$75,771,113$69,449,907-$6,321,206-8.34%
Ubs Group Ag0.01%1,317,499$71,856,395$65,861,775-$5,994,620-8.34%
Capital International Investors0.01%1,268,407$69,178,918$63,407,666-$5,771,252-8.34%
Vanguard Capital Management Llc0.00%1,181,847$64,457,935$59,080,532-$5,377,403-8.34%
Bank Of America Corp0.00%1,155,105$62,999,405$57,743,699-$5,255,706-8.34%
Nea Management Company, Llc3.64%1,058,570$57,734,408$52,917,914-$4,816,494-8.34%
Charles Schwab Investment Management Inc0.01%1,057,837$57,694,430$52,881,272-$4,813,158-8.34%
D. E. Shaw & Co., Inc.0.03%893,812$48,748,506$44,681,662-$4,066,844-8.34%
Morgan Stanley0.00%879,949$47,992,455$43,988,651-$4,003,804-8.34%
Northern Trust Corp0.01%863,091$47,072,983$43,145,919-$3,927,064-8.34%
Vanguard Portfolio Management Llc0.00%648,713$35,380,807$32,429,163-$2,951,644-8.34%
Vanguard Fiduciary Trust Co0.01%570,040$31,089,982$28,496,300-$2,593,682-8.34%
Citadel Advisors Llc0.01%465,796$25,404,514$23,285,142-$2,119,372-8.34%
Jpmorgan Chase & Co0.00%431,669$24,569,275$21,579,133-$2,990,142-12.17%
Susquehanna International Group, Llp0.02%427,178$23,298,288$21,354,628-$1,943,660-8.34%
Millennium Management Llc0.01%382,032$20,836,025$19,097,780-$1,738,245-8.34%
Iq Eq Fund Management (Ireland) Ltd1.33%381,991$20,833,789$19,095,730-$1,738,059-8.34%
Bank Of New York Mellon Corp0.00%326,761$17,821,531$16,334,782-$1,486,749-8.34%
Logos Global Management Lp0.70%300,000$16,362,000$14,997,000-$1,365,000-8.34%
Squarepoint Ops Llc0.03%286,789$15,641,472$14,336,582-$1,304,890-8.34%
Jump Financial, Llc0.14%277,952$15,159,502$13,894,820-$1,264,682-8.34%
Dimensional Fund Advisors Lp0.00%275,375$15,034,803$13,765,996-$1,268,807-8.44%
Goldman Sachs Group Inc0.00%272,372$14,855,182$13,615,876-$1,239,306-8.34%
Norges Bank0.00%270,756$14,767,032$13,535,092-$1,231,940-8.34%
Wells Fargo & Company/Mn0.00%263,169$14,353,246$13,155,818-$1,197,428-8.34%
Ameriprise Financial Inc0.00%250,614$13,669,977$12,528,194-$1,141,783-8.35%
Vestmark Advisory Solutions, Inc.0.12%242,266$13,213,188$12,110,877-$1,102,311-8.34%
Raymond James Financial Inc0.00%231,988$12,652,626$11,597,080-$1,055,546-8.34%
Nuveen, Llc0.00%203,089$11,076,474$10,152,419-$924,055-8.34%
Royal Bank Of Canada0.00%173,045$9,438,000$8,650,520-$787,480-8.34%
Marex Group Plc0.08%170,584$9,303,652$8,527,494-$776,158-8.34%
Swiss National Bank0.00%169,200$9,228,168$8,458,308-$769,860-8.34%
Susquehanna Portfolio Strategies, Llc0.14%164,026$8,945,978$8,199,660-$746,318-8.34%
Legal & General Group Plc0.00%163,810$8,934,198$8,188,862-$745,336-8.34%
Lpl Financial Llc0.00%153,581$8,376,280$7,677,514-$698,766-8.34%
Versant Venture Management, Llc4.99%148,831$8,117,243$7,440,062-$677,181-8.34%
Showing 50 of 507

Frequently asked questions about CRSP

  • Who are the largest institutional holders of CRSP?

    The largest institutional holders of CRSP reported in the latest SEC Form 13F filings include Banque Cantonale Vaudoise, ARK Invest, Blackrock, Inc., Orbis Allan Gray Ltd, and Capital World Investors. InsiderSet ranks institutional holders by their latest reported CRSP position.

  • What is CRSP institutional ownership?

    This page tracks CRSP positions reported by institutional investment managers through SEC Form 13F. CRISPR Therapeutics AG (CRSP) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own CRSP?

    InsiderSet currently tracks 507 institutional managers reporting CRSP holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of CRSP shareholders.

  • How much CRSP stock do institutions own?

    Institutional investment managers disclosed approximately $5.45B in CRSP holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was CRSP institutional ownership last updated?

    The latest CRSP institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional CRSP holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its CRSP position after the reporting date.

  • Are institutions buying or selling CRSP?

    Institutional buying and selling can be analyzed by comparing CRSP positions across consecutive 13F reporting periods. InsiderSet's CRSP Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View CRSP ownership changes.

  • How has CRSP institutional ownership changed over time?

    InsiderSet tracks CRSP institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.